Phase 4 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with COPD (chronic obstructive pulmonary disease)
- People aged 40 years or older, male or female
- People who currently smoke or used to smoke, with a history of at least 20 pack-years (for example, one pack per day for 20 years, or two packs per day for 10 years)
- People whose breathing test results show a reduced ratio of air blown out quickly compared to total air capacity, falling below the normal range
- People whose total lung capacity on a breathing test increases by at least 10% after inhaling a reliever medication called salbutamol
- People whose resting lung air volume is higher than normal (at least 120% of what is expected, or above the upper limit of normal)
- People who experience at least a moderate level of breathlessness in daily life, as measured by a standard scale called the Modified Medical Research Council dyspnea scale (score of 2 or higher)
- People who have been medically stable, with no flare-ups of their COPD in the six weeks before joining
- People who are able to give informed consent and complete all study procedures
Who may not be able to join:
- People who have significant heart or lung conditions other than COPD, such as asthma, scarring of the lungs, high blood pressure in the lungs, or heart failure
- People who have diseases affecting their muscles or bones
- People who need oxygen during the day, or whose oxygen levels drop very low (below 80%) during exercise when breathing normal room air
- People who have any other condition that could cause breathlessness or difficulty exercising
- People who have any medical reason that makes exercise testing unsafe or unsuitable for them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: J Alberto Neder, MD, PhD, Queen's University
Phone: 800-985-8891
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Airway resistance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.